Baloxavir marboxil is an orally active antiviral prodrug that appears as a white to off-white powder. It inhibits the influenza virus polymerase acidic (PA) endonuclease, blocking viral replication, and is used for the treatment and prophylaxis of influenza A and B.
Baloxavir marboxil
Category:Organic Intermediates
CAS No.:1985606-14-1
Product Grade: Pharmaceutical Grade
Purity / Assay: 98%
Molecular Formula:C₂₇H₂₃F₂N₃O₇S
Molecular Weight:571.55
EINECS No.:606-227-7
Synonym(s):Baloxavir marboxil; Xofluza
Baloxavir marboxil is an orally active antiviral prodrug that appears as a white to off-white powder. It inhibits the influenza virus polymerase acidic (PA) endonuclease, blocking viral replication, and is used for the treatment and prophylaxis of influenza A and B.
1. Used for the treatment of acute uncomplicated influenza in patients symptomatic for no more than 48 hours.
2. Serves as post-exposure prophylaxis against influenza following contact with an infected individual.
3. Functions as a cap-dependent endonuclease inhibitor with a novel mechanism distinct from neuraminidase inhibitors.
4. Provides a pharmaceutical reference standard and research tool for antiviral drug development.
25kg/drum; 25kg/bag
CAS No.: 1985606-14-1
Product Name: Baloxavir marboxil
Purity / Assay:98%
Molecular Formula:C₂₇H₂₃F₂N₃O₇S
Molecular Weight:571.55
EINECS No.:606-227-7
Synonym(s):Baloxavir marboxil; Xofluza
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.